Baicalein is a novel TLR4‐targeting therapeutics agent that inhibits TLR4/HIF‐1α/VEGF signaling pathway in colorectal cancer

• Minting Chen,
• Keying Zhong,
• Jincheng Tan,
• Mingjing Meng,
• Chok Mei Liu,
• Baisen Chen,
• Chunhua Huang,
• Hoi Leong Xavier Wong,
• Zhaoxiang Bian,
• Tao Su,
• Hiu Yee Kwan

Affiliations

Minting Chen

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Keying Zhong

International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China

Jincheng Tan

International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China

Mingjing Meng

International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China

Chok Mei Liu

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Baisen Chen

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Chunhua Huang

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Hoi Leong Xavier Wong

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Zhaoxiang Bian

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China

Tao Su

International Institute for Translational Chinese Medicine Guangzhou University of Chinese Medicine Guangzhou Guangdong China

Hiu Yee Kwan

Centre for Cancer and Inflammation Research, School of Chinese Medicine Hong Kong Baptist University Hong Kong China